← Every company
Vaxcyte Inc SEC Filings
What Vaxcyte Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
PCVX overview →Filings on file
81
since May 22, 2020
Warning signs
0
none filed
Last results
Aug 5, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Oct 9, 2026 | Material agreementNew debt 8-K | Read ↗ |
| Sep 3, 2026 | Executive or director change 8-K | Read ↗ |
| Aug 5, 2026 | Quarterly report 10-Q | Read ↗ |
| Aug 5, 2026 | Results announced 8-K | Read ↗ |
| Jul 15, 2026 | Executive or director change 8-K | Read ↗ |
| Jun 23, 2026 | Executive or director change 8-K | Read ↗ |
| Jun 16, 2026 | Shareholder vote 8-K | Read ↗ |
| May 6, 2026 | Quarterly report 10-Q | Read ↗ |
| May 6, 2026 | Results announced 8-K | Read ↗ |
| Feb 24, 2026 | Annual report 10-K | Read ↗ |
| Feb 24, 2026 | Results announced 8-K | Read ↗ |
| Dec 19, 2025 | Executive or director change 8-K | Read ↗ |
| Nov 4, 2025 | Quarterly report 10-Q | Read ↗ |
| Nov 4, 2025 | Results announced 8-K | Read ↗ |
| Sep 30, 2025 | Material agreement 8-K | Read ↗ |
| Aug 6, 2025 | Quarterly report 10-Q | Read ↗ |
| Aug 6, 2025 | Results announced 8-K | Read ↗ |
| Jun 17, 2025 | Shareholder vote 8-K | Read ↗ |
| May 7, 2025 | Quarterly report 10-Q | Read ↗ |
| May 7, 2025 | Results announced 8-K | Read ↗ |
| May 1, 2025 | Executive or director change 8-K | Read ↗ |
| Feb 25, 2025 | Annual report 10-K | Read ↗ |
| Feb 25, 2025 | Results announced 8-K | Read ↗ |
| Nov 21, 2024 | Material agreement 8-K | Read ↗ |
| Nov 5, 2024 | Quarterly report 10-Q | Read ↗ |
| Nov 5, 2024 | Results announced 8-K | Read ↗ |
| Aug 6, 2024 | Quarterly report 10-Q | Read ↗ |
| Aug 6, 2024 | Results announced 8-K | Read ↗ |
| Jul 2, 2024 | Executive or director change 8-K | Read ↗ |
| Jun 10, 2024 | Shareholder vote 8-K | Read ↗ |
| May 8, 2024 | Quarterly report 10-Q | Read ↗ |
| May 8, 2024 | Results announced 8-K | Read ↗ |
| Feb 27, 2024 | Annual report 10-K | Read ↗ |
| Feb 27, 2024 | Results announced 8-K | Read ↗ |
| Nov 28, 2023 | Executive or director change 8-K | Read ↗ |
| Nov 27, 2023 | Material agreement 8-K | Read ↗ |
| Nov 6, 2023 | Quarterly report 10-Q | Read ↗ |
| Nov 6, 2023 | Results announced 8-K | Read ↗ |
| Oct 16, 2023 | Material agreement 8-K | Read ↗ |
| Oct 4, 2023 | Material agreement 8-K | Read ↗ |
| Sep 7, 2023 | Material agreement 8-K | Read ↗ |
| Aug 8, 2023 | Quarterly report 10-Q | Read ↗ |
| Aug 8, 2023 | Results announced 8-K | Read ↗ |
| Jun 15, 2023 | Shareholder vote 8-K | Read ↗ |
| May 8, 2023 | Quarterly report 10-Q | Read ↗ |
| May 8, 2023 | Results announced 8-K | Read ↗ |
| Mar 6, 2023 | Material agreement 8-K | Read ↗ |
| Feb 27, 2023 | Annual report 10-K | Read ↗ |
| Feb 27, 2023 | Results announced 8-K | Read ↗ |
| Dec 20, 2022 | Material agreement 8-K | Read ↗ |
| Dec 12, 2022 | Executive or director change 8-K | Read ↗ |
| Nov 7, 2022 | Results announced 8-K | Read ↗ |
| Nov 7, 2022 | Quarterly report 10-Q | Read ↗ |
| Aug 8, 2022 | Results announced 8-K | Read ↗ |
| Aug 8, 2022 | Quarterly report 10-Q | Read ↗ |
| Jun 7, 2022 | Shareholder vote 8-K | Read ↗ |
| May 9, 2022 | Results announced 8-K | Read ↗ |
| May 9, 2022 | Quarterly report 10-Q | Read ↗ |
| Apr 18, 2022 | Material agreement 8-K | Read ↗ |
| Feb 28, 2022 | Results announced 8-K | Read ↗ |
| Feb 28, 2022 | Annual report 10-K | Read ↗ |
| Nov 10, 2021 | Results announced 8-K | Read ↗ |
| Nov 10, 2021 | Quarterly report 10-Q | Read ↗ |
| Oct 28, 2021 | Executive or director change 8-K | Read ↗ |
| Sep 20, 2021 | Executive or director change 8-K | Read ↗ |
| Aug 11, 2021 | Results announced 8-K | Read ↗ |
| Aug 11, 2021 | Quarterly report 10-Q | Read ↗ |
| Jun 3, 2021 | Shareholder vote 8-K | Read ↗ |
| May 11, 2021 | Results announced 8-K | Read ↗ |
| May 11, 2021 | Quarterly report 10-Q | Read ↗ |
| Mar 29, 2021 | Results announced 8-K | Read ↗ |
| Mar 29, 2021 | Annual report 10-K | Read ↗ |
| Mar 25, 2021 | Executive or director change 8-K | Read ↗ |
| Jan 25, 2021 | Material agreementNew debt 8-K | Read ↗ |
| Dec 22, 2020 | Executive or director change 8-K | Read ↗ |
| Nov 12, 2020 | Results announced 8-K | Read ↗ |
| Nov 12, 2020 | Quarterly report 10-Q | Read ↗ |
| Aug 12, 2020 | Results announced 8-K | Read ↗ |
| Aug 12, 2020 | Quarterly report 10-Q | Read ↗ |
| Jun 15, 2020 | Share offering 424B4 | Read ↗ |
| May 22, 2020 | Share offering S-1 | Read ↗ |
Source: Vaxcyte Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on PCVX
Company overviewEverything on PCVX in one place, with the price.Insider tradingWhat PCVX's own officers and directors buy and sell.Planned salesSales PCVX insiders have filed notice of.Executive payWhat PCVX awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in PCVX.Funds holding itWhich funds and ETFs hold PCVX, and how big a bet.LobbyingWhat PCVX spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on PCVX's account, and who they worked for.PatentsWhat PCVX is filing at the patent office.